TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Stockholm Vaccin-Lättakut AB
Closing information (x1000 SEK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
4,473
|
3,463
|
3,959 |
Financial expenses |
1
![]() |
1
![]() |
1 |
Earnings before taxes |
-315
|
-329
|
582 |
EBITDA |
-312
|
-325
|
587 |
Total assets |
1,976
|
2,064
|
2,446 |
Current assets |
1,959
|
2,044
|
2,424 |
Current liabilities |
625
|
398
|
449 |
Equity capital |
1,351
|
1,666
|
1,931 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
68.4%
|
80.7%
|
78.9% |
Turnover per employee |
1,491
|
1,154
|
1,320 |
Profit as a percentage of turnover |
-7.0%
|
-9.5%
|
14.7% |
Return on assets (ROA) |
-15.9%
![]() |
-15.9%
|
23.8% |
Current ratio |
313.4%
|
513.6%
|
539.9% |
Return on equity (ROE) |
-23.3%
|
-19.7%
|
30.1% |
Change turnover |
1,010
|
-496
|
-1,713 |
Change turnover % |
29%
|
-13%
|
-30% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.